Bioinformatics Market Size, Share, Trends | Global Forecast 2028

report image

Bioinformatics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Bioinformatics Platforms, Knowledge Management Tools, and Bio Informative Services), Application (Genomics, Proteomics, Chemoinformatics & Drug Design, Transcriptomics, Metabolomics, and Others), and Sector (Medical Biotechnology, Animal Biotechnology, Agricultural Biotechnology, Academics, Environmental Biotechnology, Forensic Biotechnology, and Others)

Publication Month: Aug 2022 | Report Code: TIPRE00003993 | No. of Pages: 206 | Category: Healthcare IT | Status: Published

The bioinformatics market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is estimated to grow at a CAGR of 15.7% from 2022 to 2028.     

Bioinformatics, as associated with genetics and genomics, is a scientific subdiscipline involving computer technology to collect, store, analyze, and disseminate biological data and information, such as DNA and amino acid sequences or observations about those sequences. Bioinformatics is essential for the management of data in modern biology and medicine. Scientists and clinicians use databases that organize and guide biological information to increase the understanding of health and disease and, in certain cases, as part of medical care.

Bioinformatics Market - Strategic Insights

Report Coverage - Bioinformatics Market
Report CoverageDetails
Market Size Value inUS$ 12,609.39 Million in 2021
Market Size Value byUS$ 34,749.78 Million by 2028
Growth rateCAGR of 15.7% from 2022 to 2028
Forecast Period2022-2028
Base Year2022
No. of Pages206
No. of Tables133
No. of Charts & Figures81
Historical data availableYes
Segments coveredProduct, Application, and Sector
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

The bioinformatics market is segmented based on product, application, sector, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market, emphasizing on parameters, such as market trends and dynamics, and the competitive analysis of the globally leading market players.     

Lucrative Regions for Bioinformatics Market

Lucrative Regions for Bioinformatics Market

Get more information on this report :

Market Insights

Increasing Funding and Investments in Bioinformatics

Many private organizations and government bodies around the globe are progressively investing in the field of bioinformatics. These investments have largely resulted in data and technological advancements in bioinformatics services, which have developed the quality of bioinformatics services. For instance, in 2016, the European Molecular Biology Laboratory (EMBL), an intergovernmental organization and pioneer in bioinformatics research, received funds from various organizations such as British Heart Foundation, Biotechnology and Biological Sciences Research Council, European Molecular Biology Organization, Cancer Research UK, the European Research Council, the European Commission, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program, International Policy Governance Organization, the Medical Research Council, the National Institutes of Health, National Science Foundation, Parkinson's UK, Research Councils UK, and Wellcome, for R&D in the field of bioinformatics.

In 2021, the US government announced an investment worth US$ 1.7 billion to enhance monitoring, detection, and mitigation of SARS-CoV-2 variants and infrastructure development for future genomic sequencing needs. Also, in 2021, LifeArc (London) announced US$ 6.91 million in funding to support the Gen OMICC COVID-19 study, which will also support the bioinformatics analysis of patients, costs of patient enrolment, sample acquisition, and sample processing. Moreover, many countries are investing in their national population sequencing programs to identify the link between genetics and diseases. Government organizations are sequencing the genomes of millions of citizens to advance research and help develop better techniques to diagnose and treat cancer, rare diseases, and other conditions. Thus, the funding and investment in bioinformatics are boosting the market growth.

Bioinformatics Market - Product Insights

Based on product, the bioinformatics market is segmented into bioinformatics platforms, knowledge management tools, and bioinformative services. The bioinformatics platforms segment holds the largest market share in 2021. The knowledge management tools segment is anticipated to register the highest CAGR during the forecast period. The bioinformatics platform helps generate massive patient information datasets, mapping their entire genome—as opposed to a single panel of DNA to provide improved diagnosis and more targeted and effective treatments. The rapid development of next-generation sequencing technology has dramatically increased the amount of available microbial genomes, boosting bioinformatics platforms' adoption.

Bioinformatics Market, by Product – 2022 and 2028

Bioinformatics Market, by Product – 2022 and 2028

Get more information on this report :

Bioinformatics Market - Application Insights

Based on application, the bioinformatics market is segmented into genomics, proteomics, chemoinformatics & drug design, transcriptomics, metabolomics, and others. The genomics segment holds the largest market share in 2021. Furthermore, the chemoinformatics & drug design segment is expected to record a fastest CAGR from 2022 to 2028. Genetics is currently one of the most dynamic sciences in medicine, and genetic data plays a vital role in all areas of medicine. The data generated by genomics is probably analyzed by the same methods used by physicists and engineers who study financial markets and fiber optics but analyzing the data in a way that makes sense requires knowledge of biology. Thus, bioinformatics became an invaluable hybrid field of knowledge.

Bioinformatics Market - Sector Insights

Based on sector, the bioinformatics market is segmented into medical biotechnology, animal biotechnology, agricultural biotechnology, academics, environmental biotechnology, forensic biotechnology, and others. in 2021, the medical biotechnology segment holds the largest market share. Furthermore, the same segment is expected to register the highest CAGR from 2022 to 2028. Medical bioinformatics improves the efficacy of sequencing procedures and aids in the elimination of errors that can occur with standard sequencing methods. Agrigenomics, human diseases, animal livestock, and microbes all benefit from these services.

Inorganic developments such as mergers and acquisitions are highly adopted strategies by companies in the bioinformatics market. A few of the recent key market developments are listed below: 

  • In January 2022, Thermo Fisher completed the acquisition of PeproTech on December 30, 2021, for a total cash purchase price of approximately US$ 1.85 billion. PeproTech is a privately held provider of bioscience reagents known as recombinant proteins, including cytokines and growth factors. Recombinant proteins are used in the development and manufacturing of cell and gene therapies, as well as in broader cell culture applications, especially for use in cellular research models.
  • In May 2022, Bruker Corporation and TOFWERK AG announced a strategic partnership for high-speed, ultra-sensitive applied and industrial analytical solutions, in conjunction with a Bruker minority investment in TOFWERK. The partnership provides a basis for technology collaborations to advance instrument capabilities and for the development of novel analytical applications where high speed and ultra-sensitivity matter.    

Bioinformatics Market - Company Profiles

  • Agilent Technologies, Inc.
  • Biomax Informatics Ag
  • Bruker Corporation
  • Dassault Systems
  • Eurofins Scientific
  • Geneva Bioinformatics
  • Illumina
  • Perkinelmer
  • Qiagen
  • Thermofisher Scientific, Inc. 

Frequently Asked Questions

Bioinformatics, as associated with genetics and genomics, is a scientific subdiscipline that involves using computer technology to collect, store, analyze and disseminate biological data and information, such as DNA and amino acid sequences or observations about those sequences. Bioinformatics is essential for the management of data in modern biology and medicine. Scientists and clinicians use databases that organize and guide biological information to increase the understanding of health and disease and, in certain cases, as part of medical care.
Key factors that are driving the growth of this market increasing funding and investments in bioinformatics and increased number of genomic research activities with the corresponding adoption of bioinformatics are expected to boost the market growth for bioinformatics over the years.
The CAGR value of the bioinformatics market during the forecasted period of 2022-2028 is 15.7%.
The bioinformatics platforms segment held the largest market share of 48.47% in 2021 in the global bioinformatics market.
The genomics segment dominated the global bioinformatics market and accounted for the largest market share of 28.33% in 2021.
The medical biotechnology segment dominated the global bioinformatics market and held the largest market share of 29.18% in 2021.
The Bioinformatics market majorly consists of the players such as Agilent Technologies, Inc, Biomax Informatics Ag, Bruker Corporation, Dassault Systems, Eurofins Scientific, Geneva Bioinformatics, Illumina, Perkinelmer, Qiagen, Thermofisher Scientific, Inc. among others.
Thermo Fisher Scientific and Agilent Technologies, Inc. are the top two companies that hold huge market shares in the bioinformatics market.
Global bioinformatics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North America region is the held the largest market for the bioinformatics market during the forecast period. The large share of North America is attributed to factors such as the presence of decreased cost of sequencing, leading bioinformatics providers, government support for genomic research, increased awareness of bioinformatics services, and increased number of genomic research activities in the region are driving the growth of the bioinformatics market in North America. Also, it has a favorable funding scenario for research activities.
The bioinformatics research during the COVID-19 pandemic has given an impulse to the development and adaption of various informatics techniques, including computational methods for tracing and tracking infected people, artificial intelligence methods and robotics applications to support remote patients assistance, collaborative data infrastructures for COVID-19 research and sentiment analysis methods for monitoring the impact of lockdown measures. The introduction of genomics and bioinformatics have contributed immensely to understand infectious disease from disease pathogenesis, mechanisms and the spread of antimicrobial resistance to host immune responses.

The List of Companies - Bioinformatics Market

  1. Dassault Systèmes             
  2. Bruker Corporation            
  3. Agilent Technologies, Inc.                
  4. Eurofins Scientific                
  5. Illumina, Inc.         
  6. PerkinElmer Inc.                  
  7. QIAGEN    
  8. Thermo Fisher Scientific Inc.           
  9. Biomax Informatics AG     
  10. Genebio
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the bioinformatics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global bioinformatics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the bioinformatics market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.   
TIPRE00003993
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount